Last update :
01/07/2022
Vasodilator   Nitroprusside sodium  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Nipride Canada, Netherlands
Nipruss Egypt, Germany
Nitropress Iran, New Zealand, United States of America
Stability in solutions   Injection   Stability in solutions : Nitroprusside sodium     
Container Solvent Concentration Temperature Storage Length of time References
Glass NaCl 0,9% or Glucose 5% 0,05 & 0,1 mg/ml 25°C Protect from light
48 Hour
1037

Glass Ringer’s lactate solution 0,05 & 0,1 mg/ml 25°C Protect from light
48 Hour
1037

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,05 & 0,1 mg/ml 25°C Protect from light
48 Hour
1037

Polyvinyl chloride Ringer’s lactate solution 0,05 & 0,1 mg/ml 25°C Protect from light
48 Hour
1037

Polypropylen Syringe Glucose 5% 0,001 mg/ml 20°C Protect from light
264 Day
2028

Polypropylen Syringe Glucose 5% 0,001 mg/ml 4°C Protect from light
264 Day
2028

Polypropylen Syringe Glucose 5% 0,5 & 1,67 mg/ml 25°C Protect from light
12 Hour
633

Polypropylen Syringe Glucose 5% 1 mg/ml 25°C Protect from light
24 Hour
196

Polypropylen Syringe Glucose 5% 1 mg/ml 4°C Protect from light
9 Day
3903
Level of evidence A+


  Mentions Légales